compassionate use
Latest Past Events
Expanded Access Summit 3.0
The National Press Club 529 14th Street NW, 13th Floor, WashingtonFDA Commissioner Scott Gottlieb released new comments this week on the Agency's commitment to improving Expanded Access in the U.S. Add that to his recent memo recognizing the extraordinary potential of real-world evidence generated from pre-market clinical programs. Are you ready to use Expanded Access to engage more patients in your drug development plan? Our... Continue Reading →
Working Together to Improve Patient Access to Investigational Therapies
FDA White Oak Campus Building 31, Room 1503 (B and C), 10903 New Hampshire Avenue, Silver SpringRegister HERE and watch the live webcast To further our common commitment to improving patient access to investigational therapies, the Foundation is pleased to join FDA for Project Facilitate: Enhancing the Single Patient IND Process for Oncology Health Care Providers. This public workshop brings all stakeholders together to discuss FDA’s Project Facilitate and the Expanded Access... Continue Reading →
FDA’s Annual Public Meeting
PEW Charitable Trust 901 E St NW, WashingtonJoin us for an in-depth discussion with FDA Center Directors including Drs. Peter Marks, Susan Mayne, Jeffrey Shuren, and Janet Woodcock on how Public-Private Partnerships can help FDA address its most pressing priorities. Michael McCaughan, Co-Founder of Prevision Policy, will moderate the panel at the Reagan-Udall Foundation for the FDA’s 2019 Annual Public Meeting.